| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 4,527 | 3,552 | 1,066 |
|
Selling General and Administrative | 5,372 | 6,857 | 3,817 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(9,899)
|
(10,409)
|
(4,883)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 224 | (506) | (746) |
|
Earnings Before Interest And Taxes | (9,675) | (10,915) | (5,629) |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | (9,675) | (10,915) | (5,629) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (9,675) | (10,915) | (5,629) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(9,675)
|
(10,915)
|
(5,629)
| | Preferred Stock And Other Adjustments | (1,206) | (1,798) | (3,080) | | |
Net Income Applicable To Common Shares
|
(10,881)
|
(12,713)
|
(8,709)
|
|